Advertisement
Advertisement

GHRS

GHRS logo

GH Research PLC Ordinary Shares

21.54
USD
Sponsored
+0.28
+1.32%
May 12, 16:00 UTC -4
Closed
exchange

After-Market

21.34

-0.20
-0.95%

GHRS Earnings Reports

Positive Surprise Ratio

GHRS beat 17 of 19 last estimates.

89%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

GH Research PLC Ordinary Shares earnings per share and revenue

On May 07, 2026, GHRS reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.28 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Olema Pharmaceuticals, Inc. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.53
Actual
-$0.52
Surprise
+3.60%
logo
Kura Oncology, Inc.
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.64
Actual
-$0.83
Surprise
-28.56%
logo
Arvinas, Inc
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.93
Actual
-$0.90
Surprise
+4.00%
logo
Lineage Cell Therapeutics, Inc.
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.03
Surprise
-47.06%
logo
SAB Biotherapeutics, Inc. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.23
Actual
-$0.35
Surprise
-50.28%
logo
Acumen Pharmaceuticals, Inc. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.41
Actual
-$0.33
Surprise
+19.67%
logo
Nkarta, Inc. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.38
Actual
-$0.37
Surprise
+2.63%
logo
MaxCyte, Inc. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.08
Actual
-$0.04
Surprise
+50.98%
logo
TELA Bio, Inc. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.21
Surprise
-9.37%
logo
Imunon, Inc. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$1.13
Actual
-$0.84
Surprise
+25.81%
FAQ
For Q1 2026, GH Research PLC Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for --.
Based on -- analysts, GH Research PLC Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement